US · Healthcare

Barinthus Biotherapeutics plc (BRNS)

Biotechnology

Barinthus Biotherapeutics plc (BRNS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BRNS

P/E ratio

25.00

Barinthus Biotherapeutics plc (BRNS) — FAQ

What is BRNS's P/E ratio?

The price-to-earnings (P/E) ratio for Barinthus Biotherapeutics plc (BRNS) is 25.00 (data as of 2026-05-23).

Does Barinthus Biotherapeutics plc pay a dividend?

Dividend yield is not available in the current snapshot for Barinthus Biotherapeutics plc (BRNS). Check the MyAverix Finance app for the latest dividend data.

What sector is Barinthus Biotherapeutics plc in?

Barinthus Biotherapeutics plc (BRNS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BRNS listed on?

BRNS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)